Facebook
X
LinkedIn
ForwardHow to Implement CT-guided Adaptive Radiation in Your Clinic: Practical Lessons and Streamlined Approaches Learned From Clinical Trials
Adaptive radiation therapy (RT) is an innovative treatment approach that is entering radiation oncology practice for the treatment of a variety of malignancies. Ongoing, large-scale clinical trials of CT image-guided adaptive RT have provided a framework for optimized implementation, workflow, and communication across clinics. In this session, outcomes and knowledge gained from large-scale clinical trials of CT image-guided adaptive RT will be reported. Best-practice approaches to implementing CT image-guided adaptive RT will be discussed, and strategies to streamline physics workflows and communication will be addressed.
Topics:
- Prospective Current and Future CT-guided Adaptive RT Trials; Why, When, Where, How and For Whom
Lauren Henke, MD,MS - Leveraging Knowledge Gained from Multi-center CT Guided Adaptive RT Trials-Translastion to Implementation in Your Clinic
Jonathan Leeman, MD - Standardizing CT-guided Adaptive Physics Workflows and Real-World Communications Across Clinics
Alex T. Price, PhD - Panel Discussion
Jyoti Mayadev, MD, FASTRO - Moderator
Full Panel
This activity is available from July 29, 2025, through 11:59 p.m. Eastern time on July 28, 2027.
Target Audience
The activity is designed to meet the interests of radiation oncologists and radiation oncology residents.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Better understand the current and future landscape of large-scale CT-guided adaptive RT clinical trials.
- Leverage best-practice strategies derived from large-scale clinical trials of CT-guided adaptive RT into clinical practice.
- Identify approaches to streamline CT-guided adaptive RT physics communication and workflow.
Faculty:
Lauren Henke, MD, MSCI, is employed by University Hospitals Case Medical Center. Dr. Henke is a consultant with Varian Medical Systems and serves on an advisory board with Elekta.
Jonathan Leeman, MD, is employed by Dana-Farber/Brigham and Women's Cancer Center. Dr. Leeman receives research funding from Varian Medical Systems, NH Theraguix and ViewRay, and serves on an advisory board for ViewRay.
Jyoti Mayadev, MD, FASTRO, is employed by the University of California, San Diego. Dr. Mayadev is a consultant for Varian, Merck, KORTUC, AstraZeneca and Primmune, and serves on an advisory board for Merck.
Alex T. Price, PhD, is employed by University Hospitals Cleveland Medical Center. Dr. Price is a consultant and has stock options with Aitrium.
Xenia Ray, PhD, is employed by University of California San Diego. Dr, Ray is a consultant and receives research funding from Varian and is also a consultant with KM Pharmaceutical Consulting.
Planners:
Michael Haddock, MD, FASTRO, is employed by Mayo Clinic Rochester. Dr. Haddock has no relevant financial relationships with ineligible companies.
William Small, MD, FASTRO, is employed by Loyola University Chicago. Dr. Small serves on a Data Safety Monitoring Board for Novocure and a Speaker's Bureau for Zeiss.
Parul Barry, MD, is employed by University of Pittsburgh Medical Center. Dr. Barry receives grant/research funding from Bravida Medical.
Salma Jabbour, MD, FASTRO, is employed by Rutgers University. Dr. Jabbour receives grant/research funding from Merck and Beigene and serves as a consultant for Radiologica and MX Medical.
Malcom Mattes, MD, is employed by Rutgers Cancer Institute. Dr. Mattes receives grant/research funding from Gilead Sciences.
Manisha Palta, MD, is employed by Duke Cancer Institute. Dr. Palta receives grant/research funding from Merck and Varian.
All relevant financial relationships have been mitigated.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Certificate of AttendanceThis activity was designated for 1.00 AMA PRA Category 1 Credit™.
Price
Course Fees:
ASTRO members must log in to the ASTRO website to view and receive the member rate.
- Nonmember: $149
- Member: $99
- Member-in-Training: $49
- Student/Graduate Student/PGY-1 Member: $49
- Postdoctoral Fellow Member: $49
If you are an ASTRO member from a low or lower-middle income country, as identified by the World Bank, you can receive a 50% discount off your corresponding registration for this activity. Please email [email protected] to inquire about the discount.
Policies:
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the activity by the expiration date.
Participants using ASTRO Academy activities to satisfy the requirement of a Continuing Certification (MOC) program should verify the credit number and type and availability dates of any activity before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased activities that do not align with their MOC requirement.
The activity and its materials will only be available on the ASTRO website until July 28, 2027, regardless of purchase date. At the expiration of the activity, participants will no longer have access to the activity or its materials. ASTRO reserves the right to remove an activity before its expiration date.
Required Hardware/software
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.